Rapid test for Crimean-Congo hemorrhagic fever
Part of Infections clinical trials.
This trial is developing a quick, point-of-care diagnostic test for Crimean-Congo hemorrhagic fever (CCHF), a serious viral illness. If you have symptoms and are being tested for CCHF, this study could help confirm the diagnosis faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have symptoms that suggest a possible CCHF infection
- You need a PCR test and a blood draw to check for CCHF
- You are willing to follow study procedures and give consent
- You are being seen at one of the four study sites
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different treatments for Crimean-Congo hemorrhagic fever (CCHF), a serious viral infection. It aims to find which treatment is safe and works best for patients who are hospitalized with the disease.
This trial is testing an investigational RNA vaccine to see if it is safe and helps your body build immunity against Crimean-Congo hemorrhagic fever, a serious viral disease. The study involves two injections and follow-up visits over several months.
This study tests a new rapid diagnostic tool that can quickly identify tropical fever-causing infections like malaria, dengue, Zika, chikungunya, or leptospirosis from a blood sample. The goal is to help doctors diagnose these infections faster so patients can get treatment sooner.
This trial tests a rapid diagnostic method that identifies the bacteria in your blood more quickly than standard tests. If it works, doctors can pick the right antibiotic sooner.
This study checks a new, faster test for Ebola and Lassa viruses using stored blood samples from past infections. It compares the new test's results with the original diagnosis to see if the quick test is accurate.
This trial offers free rapid testing for HIV, hepatitis C, and syphilis during street medicine visits. It helps find infections early so you can get connected to care.
Hear when a new Crimean-Congo Haemorrhagic Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.